The Dermatology
Retention Gap
661 specialist dermatologists. 2+ month wait times. 1 in 25 Australians with a chronic skin condition. And no systematic way to keep patients engaged between visits.
An Industry Under Pressure
The Workforce Gap is Growing
A projected shortfall of 90 FTE dermatologists by 2030. Demand is rising, supply is not keeping up, and patients are falling through the cracks.
The Economics of
Dermatology Access
What We See Across
Dermatology Practices
Every dermatology practice has patients who need ongoing care but have no system prompting them to return. With 2+ month wait times, delayed re-engagement means lost clinical continuity and lost revenue.
The Dermatology
Dropout Pattern
Skin conditions are chronic by nature. Eczema, psoriasis, actinic damage, skin cancer surveillance - all require regular review. But without a prompt, patients drift.
of GP consultations involve
a skin condition
Yet only 8% of skin problems are referred to a specialist. 66% of GPs never use dermoscopy. Patients who do see a dermatologist and then lapse are falling back into a primary care system not equipped for their needs.
Three Revenue Streams,
One Patient File
Dermatology sits at the intersection of medical necessity, chronic disease management, and elective aesthetics. Each stream has different recall cadences and different patient motivations.
Medical Dermatology
Skin cancer checks, mole mapping, excisions. Annual or 6-monthly surveillance. Clinical urgency drives return - but only if patients are prompted.
Chronic Conditions
Eczema, psoriasis, rosacea, acne. Ongoing management with 3-6 month review cycles. Patients lapse when symptoms ease - then relapse without support.
Cosmetic & Aesthetic
Laser, injectables, skin rejuvenation. $239M devices market growing at 11%+ CAGR. Treatment fading drives natural recall windows.
The Revenue Sitting
in Your Patient File
A typical dermatology practice with 2,000+ patients has hundreds who are overdue for review. At $166-$297 per consultation, even modest reactivation rates generate significant returns.
Already Working in
Allied Health
Routiq has been deployed across physiotherapy, podiatry, and cosmetics practices. The pattern is consistent: practices have a massive untapped recall opportunity and zero infrastructure to capture it.
“We already send recall letters”
Most dermatology practices rely on generic recall letters or no recall at all. The difference is intelligence - knowing which patients need what, when, and saying it in a way that drives action.
Behavioural Science,
Not Marketing
Every message is engineered using established psychological frameworks. We match the right principle to each patient's clinical context and time since last visit.
Loss Aversion
Skin cancer surveillance patients respond to the risk of missing early detection - their previous investment in screening has value they can protect.
Status Quo Bias
Chronic condition patients default to not acting. Messages reframe the follow-up as a continuation of their existing care plan, not a new decision.
Endowment Effect
Cosmetic patients have already invested in skin quality. Messages anchor to protecting their existing results rather than selling new treatments.
Skin Cancer Surveillance - 14 Months Since Last Check
Uses Loss Aversion (protecting previous screening investment) and Anchoring (their existing baseline is waiting for comparison). Clinically framed, not promotional.
Chronic Eczema - 5 Months Since Last Review
Uses Status Quo Bias (continuing existing care, not starting new) and Goal Gradient (they are closer to stable management than they think). Frames the visit as maintenance, not intervention.
Campaign Architecture
Not batch-and-blast. Intelligent segmentation based on treatment history, condition type, and time elapsed. Every message is reviewed by your team before it sends.
Connect
Routiq syncs with your practice management system. Patient history, appointment types, and contact details are mapped automatically.
Segment
Patients are grouped by condition type, last visit date, and recall urgency. Skin cancer surveillance, chronic conditions, and cosmetic patients get different cadences.
Draft
AI generates personalised messages using behavioural science principles matched to each segment. Every message lands in your review queue first.
Review & Send
Your team approves, edits, or skips each message. Nothing goes out without clinical sign-off. Responses are tracked and fed back into the system.
Why Routiq for
Dermatology
Multi-Stream Intelligence
Dermatology is unique - medical, chronic, and cosmetic patients in one file. Routiq understands the different recall logic for each stream and messages accordingly.
Clinical Tone
Skin cancer recall is sensitive. Chronic condition messaging requires empathy. Cosmetic follow-up needs subtlety. Every message matches the clinical context.
Practitioner Control
Full review queue with approve, edit, skip. Your dermatologists and practice managers maintain complete control over patient communication.
What Changes
Without Routiq
- Generic recall letters (if any)
- Same message for skin cancer and eczema patients
- No visibility into who is overdue
- Receptionist manually checks patient files
- Patients lapse silently
- Revenue leaks to GP-managed care
With Routiq
- Condition-specific, timed outreach
- Different messaging per treatment stream
- Real-time dashboard of overdue patients
- AI drafts reviewed by your team
- Patients prompted at the right moment
- Revenue captured from existing patient base
The Compound Effect
Dermatology has natural compounding: skin cancer patients need annual checks indefinitely. Chronic condition patients need ongoing management. Cosmetic patients return on treatment cycles. Each reactivated patient generates recurring value.
Your Practice,
Your Numbers
A quick model for a dermatology practice with 1,500 patient records.
from one campaign.
No new patients. No advertising. No additional clinical hours. Just intelligent re-engagement of people who already know and trust your practice.
See Your Own Numbers
Connect your practice management system and we will show you exactly how many patients are overdue, what they are overdue for, and the revenue opportunity sitting in your patient file. Takes less than 2 hours to set up.
Book a Demo
routiq.ai/demo
Sources
- Australasian College of Dermatologists (ACD) - Workforce Data 2024
- Cancer Australia - Melanoma Statistics 2024
- AIHW / PHRP - Skin Cancer Economics 2022
- Australian Skin Cancer Foundation - Prevalence Data 2024
- Dept of Health - Australia's Future Health Workforce: Dermatology 2017
- NHWDS - Dermatology Factsheet 2016
- ACD - Cost to See a Dermatologist 2025
- The Canberra Times / ABS - Dermatology Patient Crisis 2024
- PMC / Australasian Journal of Dermatology - GP Skin Consultations 2025
- Family Practice / Oxford Academic - GP Dermoscopy Usage 2025
- Eczema Support Australia - Burden of Eczema 2023
- PMC / Australasian Journal of Dermatology - Psoriasis Prevalence 2022
- Mordor Intelligence - Aesthetic Devices Market 2025
- Grand View Research - Facial Injectables Market 2023
- IMARC Group - Medical Aesthetics Market 2024
- Bonafide Research - Dermatology Laser Market 2026
- Australasian Journal of Dermatology - Teledermatology 2024
- Routiq Platform Data 2024-2025